Search Results - "Enríquez de Salamanca, R"

Tumour VEGF/Non Tumour VEGF protein expression ratio as a biomarker for survival in colorectal cancer patients by Morales-Gutiérrez, C, Abad-Barahona, A, Moreno-González, E, Enríquez de Salamanca, R, Vegh, I

“…Abstract Aims Vascular endothelial growth factor (VEGF) over-expression is frequently considered as a marker of both, a poor prognosis and of an aggressive…”
Get full text

Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population by Colombo, F.P., Rossetti, M.V., Méndez, M., Martínez, J.E., Enríquez de Salamanca, R., del C. Batlle, A.M., Parera, V.E.

“…Background  Combined inheritance of genetic variants in ferrochelatase gene (FECH) are implicated in clinical manifestation of Erythropoietic Protoporphyria…”
Get full text

Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury by Berasain, C, Sampedro, A, Mauleón, I, Goñi, S, Latasa, M U, Matscheko, N, García-Bravo, M, Unzu, C, Corrales, F J, Enríquez de Salamanca, R, Prieto, J, Avila, M A, Fontanellas, A

“…Activation of the epidermal growth factor receptor (EGFR) plays an important role in liver regeneration and resistance to acute injury. However its chronic…”
Get more information

The photodynamic and non-photodynamic actions of porphyrins by Afonso, S G, Enríquez de Salamanca, R, Batlle, A M

“…Porphyrias are a family of inherited diseases, each associated with a partial defect in one of the enzymes of the heme biosynthetic pathway. In six of the…”
Get full text

Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene by Méndez, M., Poblete-Gutiérrez, P., García-Bravo, M., Wiederholt, T., Morán-Jiménez, M.J., Merk, H.F., Garrido-Astray, M.C., Frank, J., Fontanellas, A., Enríquez de Salamanca, R.

“…Summary Background  Porphyria cutanea tarda (PCT) results from decreased hepatic uroporphyrinogen decarboxylase (UROD) activity. In the majority of patients,…”
Get full text

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease by JIMENEZ-JIMENEZ, F. J, DE BUSTOS, F, ENRIQUEZ-DE-SALAMANCA, R, MOLINA, J. A, BENITO-LEON, J, TALLON-BARRANCO, A, GASALLA, T, ORTI-PAREJA, M, GUILLAMON, F, RUBIO, J. C, ARENAS, J

“…We compared CSF and serum levels, and the CST/serum ratio of alpha-tocopherol (vitamin E), measured by HPLC, in 44 apparently well-nourished patients with…”
Get full text

Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease by MOLINA, J. A, JIMENEZ-JIMENEZ, F. J, VARGAS, C, GOMEZ, P, DE BUSTOS, F, ORTI-PAREJA, M, TALLON-BARRANCO, A, BENITO-LEON, J, ARENAS, J, ENRIQUEZ-DE-SALAMANCA, R

“…We measured the CSF levels of 21 and the plasma levels of 24 amino acids in 37 patients with Alzheimer's disease (AD) and in 32 matched controls. We used an…”
Get full text

Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis by DE BUSTOS, F, JIMENEZ-JIMENEZ, F. J, ARENAS, J, DE SALAMANCA, R. E, MOLINA, J. A, ESTEBAN, J, GUERRERO-SOLA, A, ZURDO, M, ORTI-PAREJA, M, TALLON-BARRANCO, A, GOMEZ-ESCALONILLA, C, RAMIREZ-RAMOS, C

“…We compared CSF and serum levels, and the CSF/serum ratio of alpha-tocopherol (vitamin E), measured by HPLC, in 30 patients with sporadic amyotrophic lateral…”
Get full text

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease by MOLINA, J. A, DE BUSTOS, F, JIMENEZ-JIMENEZ, F. J, BENITO-LEON, J, ORTI-PAREJA, M, GASALLA, T, TALLON-BARRANCO, A, NAVARRO, J. A, ARENAS, J, ENRIQUEZ-DE-SALAMANCA, R

“…We compared CSF and serum levels, and the CSF/serum ratio of alpha-tocopherol (vitamin E), measured by HPLC, in 34 patients with Parkinson's disease (PD) and…”
Get full text

Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria by Méndez, M, Morán-Jiménez, M J, Gomez-Abecia, S, García-Bravo, M, Garrido-Astray, M C, Fontanellas, A, Poblete-Gutiérrez, P, Frank, J, Enriquez de Salamanca, R

“…Acute intermittent porphyria (AIP), the most common acute hepatic porphyria, is an autosomal dominant disorder with low penetrance that results from a partial…”
Get more information

Nonsynergic Effect of Ethanol and Lead on Heme Metabolism in Rats by Santos, J.L., Fontanellas, A., Morán, M.J., Enrȷquez de Salamanca, R.

“…The heme biosynthetic pathway is a metabolic target of alcohol and lead poisoning. To analyze the interdependence of both xenobiotics on porphyrin metabolism,…”
Get full text

Successful treatment of haemodialysis-related porphyria cutanea tarda with erythropoietin by Peces, R, Enríquez de Salamanca, R, Fontanellas, A, Sánchez, A, de la Torre, M, Caparros, G, Ferreras, I, Nieto, J

Get more information

Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients by Cruz-Rojo, J, Fontanellas, A, Morán-Jiménez, M J, Navarro-Ordóñez, S, García-Bravo, M, Méndez, M, Muñoz-Rivero, M C, de Salamanca, R Enríquez

“…Erythrocyte uroporphyrinogen decarboxylase (UROD) activity was measured to classify 118 Spanish patients with porphyria cutanea tarda (PCT) into three…”
Get more information

Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells by FONTANELLAS, A, MENDEZ, M, ENRIQUEZ DE SALAMANCA, R, DE VERNEUIL, H, MAZURIER, F, CARIO-ANDRE, M, NAVARRO, S, GED, C, TAINE, L, GERONIMI, F, RICHARD, E, MOREAU-GAUDRY, F

“…Erythropoietic protoporphyria is characterized clinically by skin photosensitivity and biochemically by a ferrochelatase deficiency resulting in an excessive…”
Get full text

Survival of patients with colorectal carcinoma : Possible prognostic value of tissular carbohydrate antigen 19.9 determination by MORALES-GUTIERREZ, C, VEGH, I, COLINA, F, GOMEZ-CAMARA, A, GARCIA-CARRANZA, A, LANDA, J. I, BALLESTEROS, D, CARREIRA, P. E, ENRIQUEZ-DE-SALAMANCA, R

“…An important goal of serum tumor marker research is to provide a test for detecting cancer in early stages. Expression of carbohydrate antigen (CA) 19.9 has…”
Get full text

Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria by Moran-Jimenez, M J, Ged, C, Romana, M, Enriquez De Salamanca, R, Taïeb, A, Topi, G, D'Alessandro, L, de Verneuil, H

“…A deficiency in uroporphyrinogen decarboxylase (UROD) enzyme activity, the fifth enzyme of the heme biosynthetic pathway, is found in patients with sporadic…”
Get full text

Hepatoerythropoietic porphyria: relationship with familial porphyria cutanea tarda by Castaño Suárez, E, Zamarro Sanz, O, Guerra Tapia, A, Enríquez de Salamanca, R

“…Hepatoerythropoietic porphyria is characterized by an early beginning of severe photosensitivity, with an increase in urinary uroporphyrin excretion and other…”
Get more information

Serum levels of coenzyme Q10 in patients with Parkinson's disease by JIMENEZ-JIMENEZ, F. J, MOLINA, J. A, ENRIQUEZ DE SALAMANCA, R, ARENAS, J, DE BUSTOS, F, GARCIA-REDONDO, A, GOMEZ-ESCALONILLA, C, MARTINEZ-SALIO, A, BERBEL, A, CAMACHO, A, ZURDO, M, BARCENILLA, B

“…We compared serum levels of coenzyme Q10 and the coenzyme Q10/cholesterol ratio in 33 patients with Parkinson's disease (PD) and 31 matched controls. The mean…”
Get full text

Porphyrin-induced protein structural alterations of heme enzymes by Afonso, S.G., Enriquez de Salamanca, R., Batlle, A.M.Del C.

“…Some alterations in the protein structure of δ-aminolevulinic acid dehydratase (ALA-D) and porphobilinogen deaminase (PBG-D) induced by uroporphyrin (URO) and…”
Get full text

Serum levels of coenzyme Q10 in patients with Alzheimer's disease by DE BUSTOS, F, MOLINA, J. A, ENRIQUEZ-DE-SALAMANCA, R, ARENAS, J, JIMENEZ-JIMENEZ, F. J, GARCIA-REDONDO, A, GOMEZ-ESCALONILLA, C, PORTA-ETESSAM, J, BERBEL, A, ZURDO, M, BARCENILLA, B, PARRILLA, G

“…We compared serum levels of coenzyme Q10 and the coenzyme Q10/cholesterol ratio in 44 patients with Alzheimer's disease (AD), 17 patients with vascular…”
Get full text